Close Menu

Columbia

The first version of the sequencer, about to enter beta-testing, will cost around $250,000 and will be able to generate several gigabases of data in a 5.5-hour run with $250 in consumables costs per gigabase. That price is expected to fall to as little as $2 with later generations.

Strands: Mar 12, 2009

Premium

Rosetta Genomics, Alnylam Pharmaceuticals, Massachusetts Institute of Technology

The firm published data from a study showing that the same biomarker used in its miRNA-based test for squamous lung cancer provided 96 percent sensitivity.

As part of the arrangement, Columbia and the University of Nebraska-Lincoln signed an inter-institutional agreement that makes Columbia the lead on patent prosecution and negotiations, but gives both universities and their faculty inventors an undisclosed equity stake in the company.

Battelle Ventures, MIT, Hepragen, Wayne State University, Defyrus, UK Ministry of Defence, Columbia U, Intelligent Bio-Systems, Kauffman Foundation

The company will use the funds to develop protein-based Alzheimer's diagnostics.

Microarrays

Short Reads: Feb 24, 2009

Premium

Intelligent Bio-Systems, Norwich Ventures, National Human Genome Research Institute, Floragenex, National Center for Genome Resources, Decode Genetics, DNAStar, Infogen

IBS has kept a relatively low profile the past couple of years, but it plans to get prototype sequencing systems into the hands of early-access customers as early as the first quartyer of this year.

Pages

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.